PAHC Stock: Price, Earnings History and SEC Filings
Phibro Animal Health Corporation (PAHC) last traded at $38.88, up 0.05% on the latest session and up 8.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.85 against an analyst estimate of $0.72, a beat of 18.1%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
PAHC earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 26, 2026 | $0.85 | $0.72 | +18.06% |
| Mar 2026 | May 6, 2026 | $0.76 | $0.72 | +5.56% |
| Dec 2025 | Feb 4, 2026 | $0.87 | $0.69 | +26.09% |
| Sep 2025 | Nov 5, 2025 | $0.73 | $0.59 | +23.73% |
PAHC beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How PAHC reacts to earnings
Across its last 8 earnings releases, PAHC moved 12.4% on average the next session, in either direction. It rose after 7 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-26 | After close | +0.72% |
| 2026-05-06 | After close | -26.22% |
| 2026-02-04 | After close | +21.95% |
| 2025-11-05 | After close | +4.59% |
| 2025-08-27 | After close | +19.44% |
| 2025-05-07 | After close | +14.75% |
| 2025-02-05 | After close | +9.88% |
| 2024-11-06 | After close | +1.78% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
PAHC financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | $1.5B | $100M | – | 6.6% | $2.43 |
| 2025 | $1.3B | $48M | – | 3.7% | $1.19 |
| 2024 | $1.0B | $2M | – | 0.2% | $0.06 |
| 2023 | $978M | $33M | – | 3.3% | $0.81 |
| 2022 | $942M | $49M | – | 5.2% | $1.21 |
| 2021 | $833M | $54M | – | 6.5% | $1.34 |
| 2020 | $800M | $34M | – | 4.2% | $0.83 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for PAHC
- DEF 14A · Sep 18, 2026
- 8-K · Aug 26, 2026Results of operations, Financial statements and exhibits
- 10-K · Aug 26, 2026
- 8-K · Jul 28, 2026Other events, Financial statements and exhibits
- 8-K · Jun 26, 2026Officer or director change
- 8-K · May 6, 2026Results of operations, Financial statements and exhibits
- 10-Q · May 6, 2026
- 8-K · May 5, 2026Other events, Financial statements and exhibits
- 8-K · Apr 30, 2026Material agreement, New financial obligation, Financial statements and exhibits
- 8-K · Apr 27, 2026Regulation FD disclosure, Financial statements and exhibits
Insider filing activity
PAHC insiders filed 14 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
PAHC news
- Cencora Gears Up to Report Q4 Results: How to Play the Stock?Oct 30, 2026 · finance.yahoo.com
- Revvity Gears Up to Post Q3 Earnings: What's in Store for the Stock?Oct 30, 2026 · finance.yahoo.com
- STERIS Set to Report Q2 Earnings: What's in the Cards for the Stock?Oct 30, 2026 · finance.yahoo.com
- ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock FallsOct 29, 2026 · finance.yahoo.com
- BTSG Ahead of Q3 Earnings: Can Growth Offset Ongoing IRA Risks?Oct 29, 2026 · finance.yahoo.com
- Zimmer Biomet Gears Up to Report Q3 Earnings: What's in the Cards?Oct 29, 2026 · finance.yahoo.com
- 3 value stocks with warning signsOct 29, 2026 · finance.yahoo.com
- Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter ResultsOct 28, 2026 · finance.yahoo.com
About Phibro Animal Health Corporation
Phibro Animal Health Corporation (PAHC) is a US-listed public company on Nasdaq. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in DE. Its fiscal year ends in June.